Incidence of Pulmonary and Venous Thromboembolism in Pregnancies After in Vitro Fertilisation: Cross Sectional Study

Overview

Journal BMJ

Specialty General Medicine

Date 2013 Jan 17

PMID 23321489

Citations 38

Authors

Peter Henriksson

Eli Westerlund

Hakan Wallen

Lena Brandt

Outi Hovatta

Anders Ekbom

Affiliations

Soon will be listed here.

Abstract

Objective: To estimate the risk of pulmonary embolism and venous thromboembolism in pregnant women after in vitro fertilisation.

Design: Cross sectional study.

Setting: Sweden.

Participants: 23,498 women who had given birth after in vitro fertilisation between 1990 and 2008 and 116,960 individually matched women with natural pregnancies.

Main Outcome Measures: Risk of pulmonary embolism and venous thromboembolism (identified by linkage to the Swedish national patient register) during the whole pregnancy and by trimester.

Results: Venous thromboembolism occurred in 4.2/1000 women (n=99) after in vitro fertilisation compared with 2.5/1000 (n=291) in women with natural pregnancies (hazard ratio 1.77, 95% confidence interval 1.41 to 2.23). The risk of venous thromboembolism was increased during the whole pregnancy (P<0.001) and differed between the trimesters (P=0.002). The risk was particularly increased during the first trimester, at 1.5/1000 after in vitro fertilisation versus 0.3/1000 (hazard ratio 4.22, 2.46 to 7.26). The proportion of women experiencing pulmonary embolism during the first trimester was 3.0/10,000 after in vitro fertilisation versus 0.4/10,000 (hazard ratio 6.97, 2.21 to 21.96).

Conclusions: In vitro fertilisation is associated with an increased risk of pulmonary embolism and venous thromboembolism during the first trimester. The risk of pulmonary embolism is low in absolute terms but because the condition is a leading cause of maternal mortality and clinical suspicion is critical for diagnosis, an awareness of this risk is important.

Trial Registration: ClinicalTrials.gov NCT01524393.

Citing Articles

Risk of Thrombosis in Women Undergoing In Vitro Fertilization: A Narrative Review.

Grandone E, Bitsadze V, Khizroeva J, Chinni E, Mastroianno M, Nappi L J Clin Med. 2025; 14(4).

PMID: 40004587 PMC: 11856335. DOI: 10.3390/jcm14041053.

Primary Prevention of Cardiovascular Disease in Women.

Shahid I, Avenatti E, Titus A, Al-Kindi S, Nasir K Methodist Debakey Cardiovasc J. 2024; 20(2):94-106.

PMID: 38495667 PMC: 10941704. DOI: 10.14797/mdcvj.1313.

Change of HeART: Cardiovascular Implications of Assisted Reproductive Technology.

Niazi E, Dumanski S CJC Open. 2024; 6(2Part B):142-152.

PMID: 38487072 PMC: 10935705. DOI: 10.1016/j.cjco.2023.09.008.

Managing Pulmonary Embolism With Right Ventricular Thrombus in In Vitro Fertilization-Related Pregnancy: A Clinical Insight.

Ba-Shammakh S, Al-Zughali E, Al-Shami N, Al-Darobi A, Abuaisha H, Karabsheh S Cureus. 2024; 15(12):e51383.

PMID: 38292994 PMC: 10825887. DOI: 10.7759/cureus.51383.

Values of Caprini Risk Assessment Scale and D-Dimer for Predicting Venous Thromboembolism During Puerperium.

Liu H, Li L, Zhao Z Int J Womens Health. 2024; 16:47-53.

PMID: 38229588 PMC: 10790585. DOI: 10.2147/IJWH.S443245.

References

. Ovarian hyperstimulation syndrome. Fertil Steril. 2008; 90(5 Suppl):S188-93. DOI: 10.1016/j.fertnstert.2008.08.034. View

Grady D, Wenger N, Herrington D, Khan S, Furberg C, Hunninghake D . Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study. Ann Intern Med. 2000; 132(9):689-96. DOI: 10.7326/0003-4819-132-9-200005020-00002. View

Coulam C, Jeyendran R . Thrombophilic gene polymorphisms are risk factors for unexplained infertility. Fertil Steril. 2008; 91(4 Suppl):1516-7. DOI: 10.1016/j.fertnstert.2008.07.1782. View

Marik P, Plante L . Venous thromboembolic disease and pregnancy. N Engl J Med. 2008; 359(19):2025-33. DOI: 10.1056/NEJMra0707993. View

Chan W, Ginsberg J . A review of upper extremity deep vein thrombosis in pregnancy: unmasking the 'ART' behind the clot. J Thromb Haemost. 2006; 4(8):1673-7. DOI: 10.1111/j.1538-7836.2006.02026.x. View

Cushman M, Kuller L, Prentice R, Rodabough R, Psaty B, Stafford R . Estrogen plus progestin and risk of venous thrombosis. JAMA. 2004; 292(13):1573-80. DOI: 10.1001/jama.292.13.1573. View

Clark S, Belfort M, Dildy G, Herbst M, Meyers J, Hankins G . Maternal death in the 21st century: causes, prevention, and relationship to cesarean delivery. Am J Obstet Gynecol. 2008; 199(1):36.e1-5. DOI: 10.1016/j.ajog.2008.03.007. View

Rosenberg V, Lockwood C . Thromboembolism in pregnancy. Obstet Gynecol Clin North Am. 2007; 34(3):481-500, xi. DOI: 10.1016/j.ogc.2007.06.006. View

Leung A, Bull T, Jaeschke R, Lockwood C, Boiselle P, Hurwitz L . American Thoracic Society documents: an official American Thoracic Society/Society of Thoracic Radiology Clinical Practice Guideline--Evaluation of Suspected Pulmonary Embolism in Pregnancy. Radiology. 2012; 262(2):635-46. DOI: 10.1148/radiol.11114045. View

10.

Malizia B, Hacker M, Penzias A . Cumulative live-birth rates after in vitro fertilization. N Engl J Med. 2009; 360(3):236-43. DOI: 10.1056/NEJMoa0803072. View

11.

Ludvigsson J, Otterblad-Olausson P, Pettersson B, Ekbom A . The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol. 2009; 24(11):659-67. PMC: 2773709. DOI: 10.1007/s10654-009-9350-y. View

12.

Wells P, Anderson D, Rodger M, Forgie M, Kearon C, Dreyer J . Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med. 2003; 349(13):1227-35. DOI: 10.1056/NEJMoa023153. View

13.

Lindqvist P, Dahlback B, Marsal K . Thrombotic risk during pregnancy: a population study. Obstet Gynecol. 1999; 94(4):595-9. DOI: 10.1016/s0029-7844(99)00308-7. View

14.

Westerlund E, Antovic A, Hovatta O, Eberg K, Blomback M, Wallen H . Changes in von Willebrand factor and ADAMTS13 during IVF. Blood Coagul Fibrinolysis. 2010; 22(2):127-31. DOI: 10.1097/MBC.0b013e32834363ea. View

15.

Rova K, Passmark H, Lindqvist P . Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles. Fertil Steril. 2011; 97(1):95-100. DOI: 10.1016/j.fertnstert.2011.10.038. View

16.

Henriksson P, Edhag O . Orchidectomy versus oestrogen for prostatic cancer: cardiovascular effects. Br Med J (Clin Res Ed). 1986; 293(6544):413-5. PMC: 1341234. DOI: 10.1136/bmj.293.6544.413. View

17.

Van Voorhis B . Clinical practice. In vitro fertilization. N Engl J Med. 2007; 356(4):379-86. DOI: 10.1056/NEJMcp065743. View

18.

Cutts B, Dasgupta D, Hunt B . New directions in the diagnosis and treatment of pulmonary embolism in pregnancy. Am J Obstet Gynecol. 2012; 208(2):102-8. DOI: 10.1016/j.ajog.2012.06.035. View

19.

Chan W . The 'ART' of thrombosis: a review of arterial and venous thrombosis in assisted reproductive technology. Curr Opin Obstet Gynecol. 2009; 21(3):207-18. DOI: 10.1097/GCO.0b013e328329c2b8. View

20.

Chang J, Elam-Evans L, Berg C, Herndon J, Flowers L, Seed K . Pregnancy-related mortality surveillance--United States, 1991--1999. MMWR Surveill Summ. 2003; 52(2):1-8. View